aTyr Pharma Financial Overview
aTyr Pharma's market cap is currently $73.49M. The company's EPS TTM is $-0.26; its P/E ratio is -0.87; aTyr Pharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
